Quadrant Capital Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-132
Closed -$6.52K 2796
2023
Q3
$6.52K Buy
+132
New +$6.52K ﹤0.01% 2105
2023
Q2
Sell
-15
Closed -$1.37K 2787
2023
Q1
$1.37K Sell
15
-15
-50% -$1.37K ﹤0.01% 2492
2022
Q4
$3.54K Buy
30
+15
+100% +$1.77K ﹤0.01% 2288
2022
Q3
$3K Buy
+15
New +$3K ﹤0.01% 2311